Brivanib Alaninate | Interleukin Related interleukin-related.com

Product Name :
Brivanib Alaninate

Search keywords :
Brivanib

drugId :
null

Target Vo:
Fibroblast growth factor receptor 1

Target Vo Short Name :
FGFR1

Moa_Name:
Fibroblast growth factor receptor 1 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Bristol-Myers Squibb Company

Active Company_Name :
Chongqing University Cancer Hospital

Active Indication_Name:
Uterine Cervical Neoplasms

In Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-STAT1 (Ser727) Antibody (YA149)
Cyclin D3 Antibody
PAK2 Antibody (YA695): PAK2 Antibody (YA695) is a non-conjugated and Mouse origined monoclonal antibody about 58 kDa, targeting to PAK2 (7H3). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Monkey.

Author: Interleukin Related

Related Posts